Healthcare in Japan is of a high standard with the country enjoying the highest average life expectancy and lowest infant mortality rates in the world. However, a number of inefficiencies in the system need to be addressed.
The EBC Medical Equipment Committee works closely with the Japanese Government, specifically the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA), as well as the related industry associations to establish an environment that allows innovative European medical equipment to be delivered adequately to patients in Japan.
Medical diagnostic reagents and equipment are used to perform diagnostic tests in hospitals, commercial laboratories, physicians’ offices and blood banks.
Reagents are an essential component of any healthcare regime, indispensable in preventing sickness, detecting and diagnosing diseases, ascertaining the side effects of drug therapy, monitoring treatment, improving patient quality of life and decreasing total healthcare costs. Repeated cuts to reimbursement prices have reduced pricing levels in Japan below those of comparable overseas markets. The current regulatory structure and reimbursement regime constitute an obstacle to introducing new products the Japanese market and the committee aims to overcome these problems.